Intellia Therapeutics, Inc. (NASDAQ:NTLA) Q1 2022 Earnings Conference Call May 5, 2022 8:00 AM ET Company Participants Ian Karp - SVP, IR & Corporate Communications John Leonard - President, CEO & Director David Lebwohl - EVP & Chief Medical Officer Laura Sepp-Lorenzino - EVP & Chief Scientific Officer Glenn Goddard - EVP, CFO & Treasurer Conference Call Participants Swapnil Malekar - Piper Sandler & Co. Maurice Raycroft - Jefferies Dae Gon Ha - Stifel, Nicolaus & Company Salveen Richter - Goldman Sachs Gro ...